Clinical trial
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
NCT02830724
Study timeline
Study start (actual)2017-04-06Date precision: day
Registry last updated2026-08-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pancreatic Cancerunresolved
Renal Cell Cancerunresolved
Breast Cancerunresolved
Melanomaunresolved
Ovarian Cancerunresolved
Interventions
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
FludarabineDRUG · verified · RxNorm: fludarabine
AldesleukinDRUG · verified · RxNorm: aldesleukin
Anti-hCD70 CAR transduced PBLBIOLOGICAL
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02830724 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.